Answers are grounded in this paper and cite their sources.
Preclinical in vivo study demonstrates marked therapeutic survival in lethal bacterial infections in mice, indicating penicillin's clinical potential as an antimicrobial agent.
Ernest Boris Chain was born and educated in Berlin. He obtained his doctor of philosophy from Friedrich-Whilhelms University in 1933, majoring in chemistry and physiology. Initially, he worked as a biochemist in the Institute for Pathology at the Charité Hospital in Berlin, but in 1933, because of the rise of the Nazi regime, he moved to England, where he became a British citizen. For two years, he worked in the School of Biochemistry at Cambridge, and then moved to the Sir William Dunn School of Pathology at Oxford, where he worked with Professor Howard Florey. Florey called his attention to the paper published by Alexander Fleming in 1928 which reported the observation that the mould, Penicillium notatum, produced a bacteria-inhibiting substance that Fleming had not been able to isolate. In collaboration with Florey, Chain began the study of antibacterial substances produced by microorganisms, which culminated with the discovery of the therapeutic properties of pure penicillin. This work was done under severe financial hardship because of limited support by the British Medical Research Council. Although Chain was able to produce small amounts of penicillin, he lacked the enormous resources that permitted laboratories in the United States to rapidly produce commercial quantities of the material. In 1945, Chain, Florey, and Fleming shared the Nobel Prize for “the discovery of penicillin and its curative effect in various infectious diseases.” Unable to get the research support that he believed he deserved, Chain moved to Rome where he organized a Department of Biochemistry at the State Institute of Health. At the International Centre for Chemical Microbiology, he finally had the facilities he needed for continuing his work. In 1964, Chain returned to London to the Imperial College where a well-funded position had been created for him. The last years of his life were filled with additional honors, including a knighthood in 1969. The following paper, published in 1940, was the first to establish that penicillin was effective against bacteria in vivo as well as in vitro, and opened up a new era in the treatment of bacterial infections. In recent years interest in chemotherapeutic effects has been almost exclusively focused on the sulphonamides and their derivatives. There are, however, other possibilities, notably those connected with naturally occurring substances. It has been known for a long time that a number of bacteria and moulds inhibit the growth of pathogenic micro-organisms. Little, however, has been done to purify or to determine the properties of any of these substances. The antibacterial substances produced by Pseudomonas pyocyanea have been investigated in some detail, but without the isolation of any purified product of therapeutic value. Recently, Dubos and collaborators (1939, 1940) have published interesting studies on the acquired bacterial antagonism of a soil bacterium which have led to the isolation from its culture medium of bactericidal substances active against a number of gram-positive micro-organisms. Pneumococcal infections in mice were successfully treated with one of these substances, which,however, proved to be highly toxic to mice (Hotchkiss and Dubos 1940) and dogs (McLeod et al. 1940). Following the work on lysozyme in this laboratory it occurred to two of us (E.C. and H.W.F.) that it would be profitable to conduct a systematic investigation of the chemical and biological properties of the antibacteria substances produced by bacteria and moulds. This investigation was begun with a study of a substance with promising antibacterial properties, produced by a mould and described by Fleming (1929). The present preliminary report is the result of a coöperative investigation on the chemical, pharmacological and chemotherapeutic properties of this substance. Fleming noted that a mould produced a substance which inhibited the growth, in particular, of staphylococci, streptococci, gonococci, meningococci and Corynebacterium diphtheriæ, but not of Bacillus coli, Hæmophilus influenzæ, Salmonella typhi, P. pyocyanea, Bacillus proteus or Vibrio choleræ. He suggested its use as an inhibitor in the isolation of certain types of bacteria, especially H. influenzæ. He also noted that the injection into animals of broth containing the substance, which he called “penicillin,” was no more toxic than plain broth, and he suggested that the substance might be a useful antiseptic for application to infected wounds. The mould is believed to be closely related to Penicillium notatum.Clutterbuck, Lovell and Raistrick (1932) grew the mould in a medium containing inorganic salts only and isolated a pigment-chrysogenin-which had no antibacterial action. Their culture media contained penicillin but this was not isolated. Reid (1935) reported work on the inhibitory substance produced by Fleming’s mould. He did not isolate it but noted some of its properties. During the last year methods have been devised here for obtaining a considerable yield of penicillin, and for rapid assay of its inhibitory power. From the culture medium a brown powder has been obtained which is freely soluble in water. It and its solution are stable for a considerable time and though it is not a pure substance, its anti-bacterial activity is very great. Full details will, it is hoped, be published later. EFFECTS ON NORMAL ANIMALS Various tests were done on mice, rats and cats. There is some oedema at the site of subcutaneous injection of strong solutions (e.g. 10 mg. in 0 · 3 c.cm.). This may well be due to the hypertonicity of the solution. No sloughing of skin or suggestion of serious damage has ever been encountered even with the strongest solutions or after repeated injections into the same area. Intravenous injections showed that the penicillin preparation was only slightly, if at all, toxic for mice. An intravenous injection of as much as 10 mg. (dissolved in 0 · 3 c.cm. distilled water) of the preparation we have used for the curative experiments did not produce any observable toxic reactions in a 23 g. mouse. It was subsequently found that 10 mg. of a preparation having twice the penicillin content of the above was apparently innocuous to a 20 g. mouse. Subcutaneous injections of 10 mg. into two rats at 3-hourly intervals for 56 hours did not cause any obvious change in their behaviour. They were perhaps slightly less lively than normal rats but they continued to eat their food. Their blood showed a fall of total leucocytes after 24 hours, but after 48 hours the count had risen again to about the original total. There was, however, a relative decrease in the number of polymorphs, but the normal number was restored 24 hours after stopping the administration of the substance. One of these two rats was killed for histological examination; there was some evidence that the tubule cells of the kidney were damaged. The other has remained perfectly well, and its weight increased from 76 to 110 g. in 23 days. It is to be noted that these rats received, weight for weight, about five times the dose of penicillin used in the curative experiments in mice. No evidence of toxic effects was obtained from the treated mice, which received penicillin for many days. Other pharmacological effects. On the blood-pressure, heart-beat and respiration of cats no effects have been observed after intravenous injection of 40 mg.-enough to bring up the concentration in the blood just after injection to 1/5000. Perfusion of the isolated cat’s heart, with Ringer-Locke solution containing 1/5000 penicillin produced progressive slowing during 15 minutes and at the end of that time the heart looked as though it would stop beating; however, it was quickly revived by perfusing with Ringer-Locke solution alone. The same depressant action was seen at 1/10,000 dilution but the effect was less than at 1/5000. Solutions are absorbed from the intestine in the rat without causing any observable damage to the mucosa. They are also readily absorbed after subcutaneous injection and the substance can be detected in the blood. It is excreted by the kidneys, the urine becoming bright yellow. At least 40-50% appears in the urine in a still active form. Human leucocytes remain active in a 1/1000 solution for at least 3 hours. It must be emphasised that the results of these preliminary tests have been obtained with an impure substance and such slight toxic effects as have been noted may possibly be due, in part at least, to these impurities. EFFECTS ON BACTERIA IN VITRO In view of this slight evidence of tissue toxicity it is all the more striking that the substance in a dilution of one in several hundred thousand inhibits in vitro the growth of many micro-organisms, including anaerobes. Of those so far tested in this laboratory the following are sensitive to the inhibiting action of our preparation: Clostridium welchii (2 strains); Cl. septique (1 strain, Nat. coll. type-cultures No. 458); Cl. oedematiens (1 strain, N.C.T.C. No. 277); C. diphtheriæ (1 strain, mitis type); Streptococcus pyogenes (Lancefield group A); Str. viridans (1 strain from tooth); Str. pneumoniæ (type 8); staphylococci (3 strains). Penicillin is not immediately bactericidal but seems to interfere with multiplication. THERAPEUTIC EFFECTS From all the above tests it was clear that this substance possessed qualities which made it suitable for trial as a chemotherapeutic agent. Therapeutic tests were therefore done on mice infected with streptococci, staphylococci and Cl. septique. Bacteriological methods: streptococcus and staphylococcus. The staphylococcus was kept in culture in meat extract broth and the streptococcus in the same with serum. Both organisms were repeatedly passed through mice and were used for experiment 2-4 days after the last passage. The experimental infection was induced with 20-24 hour broth cultures injected intraperitoneally. According to opacity measurements with Brown’s tubes, doses of 450 and 350 million cocci, living and dead, were given respectively in the two streptococcal experiments, and doses of 760 and 200 million in the staphylococcal experiments. Pathogenic anaerobes. The therapeutic effects were tried in mice infected with spores of Cl. septique in the manner described by Henderson and Gorer (1940). Attempts to carry out similar tests with Cl. welchii were temporarily abandoned owing to the difficulty of establishing in mice a type of infection which is both certainly fatal and allows adequate time before death for treatment to take effect. A spore suspension of Cl. septique was made by anaerobic growth at 37°C. for 48 hours on Dorset’s egg slopes, suspension of the growth of each slope (surface about 15 sq. cm.) in about 1 c.cm. of sterile distilled water, centrifugalisation, once washing with distilled water, recentrifugalisation and resuspension in the original volume of distilled water. The suspension was then heated to 75°C. for one hour. The virulence of the suspension, when injected with an equal volume of 5% calcium chloride was roughly titrated by injection into the thigh muscle of mice, and a dose was chosen for the therapeutic experiment such as would kill for certain without being unnecessarily severe, viz., 0 · 05 c.cm. of the suspension diluted one in three, mixed with 0 · 05 c.cm. of the calcium chloride solution. This was injected into the thigh muscles of 75 mice. Treatment. The general principle has been to keep up an inhibitory concentration of the substance in the tissues of the body throughout the period of treatment by repeated subcutaneous injections. No extended tests have been made to determine the minimum effective quantities or the longest intervals possible between injections. The doses employed have been effective and not toxic; they may have been excessive. The solution contained 10 mg. per c.cm. of substance. In the first streptococcal experiment the treatment was continued for 12 hours only. That this was inadequate was shown by deaths occurring during the arbitrarily chosen 10-day period. In the second experiment the time of treatment was lengthened, with improved results. In this and the two staphylococcal experiments injections were given 3-hourly for the first 32-37 hours, then at longer intervals. In preliminary experiments with Cl. septique it was found that the infection could be satisfactorily held in check so long as penicillin was being given (i.e., for 2 days) but when the administration was stopped the infection developed. In the experiment quoted, therefore, the injections were given for 10 days, 3-hourly for 41 hours, then at longer intervals, and twice daily for the last 2 days of the period. No deaths have subsequently occurred (22 days after beginning of experiment). The behaviour of the mice infected with streptococci and staphylococci was interesting. For some hours after the start of treatment they looked sick-some even appeared to be dying-but as the experiment went on they progressively improved till at the end of 24 hours in the case of the streptococci and about 36 to 48 hours with the staphylococci it was difficult or impossible to distinguish them from normal mice. The survivors of the Cl. septique infection on the other hand remained well throughout, except for a few in which leg lesions appeared near the site of injection and cleared up in a few hours. In the final streptococcus experiment (no. 2) whereas 25/25 controls died, 24/25 treated animals survived. With Staphylococcus aureus the final experiment (no. 2) shows 24/24 deaths of the controls and 21/24 survivals among the treated. Lastly, with Cl. septique when the larger doses of penicillin were given (bottom line) the figures are 25/25 control deaths and 24/25 treatment survivals. CONCLUSIONS The results are clear cut, and show that penicillin is active in vivo against at least three of the organisms inhibited in vitro. It would seem a reasonable hope that all organisms inhibited in high dilution in vitro will be found to be dealt with in vivo. Penicillin does not appear to be related to any chemotherapeutic substance at present in use and is particularly remarkable for its activity against the anaerobic organisms associated with gas gangrene.
No takes yet. Share an insight, caveat, or question.
Chain et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: